Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer

詳細情報 詳細情報について

• CRID

  1363951793607647104

• DOI

  10.1016/j.ctrv.2015.08.002

• ISSN

  03057372

• Web Site

  https://api.elsevier.com/content/article/PII:S0305737215001644?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0305737215001644?httpAccept=text/plain

• データソース種別

  • Crossref